Department of Neurology
Research
Patient Care
Education
Faculty
Administration
Department Facts
Giving
Jill Ostrem, M.D., Associate Professor Neurology

Medical Director UCSF Surgical Movement Disorders Program

Phone: 415-502-3576 (office) 415-353-2311 (Appointments)
Fax: 415-353-9060
Email: jill.ostrem@ucsf.edu
Box #: 0138

Dr. Jill Ostrem is the medical director of the UCSF Surgical Movement Disorders Program. Working with her colleagues Drs. William Marks, Jr., Graham Glass and Nicholas Galifianakis in neurology and Drs. Starr and Larson, the programs focus is on offering comprehensive multidisciplinary care to movement disorder patients considering or undergoing surgical treatment for their movement disorders. Her main clinical focus is on treating patients with Parkinson's disease, essential tremor, and dystonia with deep brain stimulation (DBS).

Her research interests focus on clinical trails of DBS in PD, essential tremor and dystonia; understanding outcomes in patients undergoing DBS lead placement with a new interventional MRI surgical technique; investigating new DBS systems; and gene therapy for movement disorders.

She also serves is co-director of the UCSF Surgical Movement Disorders botulinum toxin clinic and is involved in research in this area as well.

Ostrem earned a medical degree at George Washington University in Washington, D.C. and completed a residency in neurology and a fellowship in movement disorders at UCLA Medical Center. She is an Associate Professor of Neurology in the UCSF School of Medicine and a member of the American Academy of Neurology and the Movement Disorders Society.

Selected Publications

Ostrem JL, Marks WJ, Volz M, Heath S, Starr PA. Pallidal Deep Brain Stimulation in Patients with Cranial-Cervical Dystonia (Meige Syndrome). Mov Disord. 22(13):1885-1891: 2007.

Marks WJ, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT.  A Phase I, Open-Label Study of CERE-120 (Adeno-Associated Virus Serotype [AAV2]-Neurturin [NTN]) to Assess the Safety and Tolerability of Intraputaminal Delivery to Subjects with Idiopathic Parkinson's Disease. Lancet Neurol. 7(5):400-4008:2008.

Ostrem JL, Starr PA. Treatment of Dystonia with Deep Brain Stimulation. Neurotherapeutics. 5(2):320-330:2008.

Berman B, Starr PA, Marks WJ, Ostrem JL. Induction of Bradykinesia with Pallidal Deep Brain Stimulation in Patients with Cranial-Cervical Dystonia. Stereotact Funct Neurosurg. 87(1):37-44: 2009.

Martin AJ, Larson PS, Ostrem JL, Starr PA. Interventional MR guidance of deep brain stimulator implantation for Parkinson’s disease. Top Magn Reson Imaging. 19(4):213-21:2009.

 

 

 

 

Quick Links
Make a Gift